Research output per year
Research output per year
Fingerprint
Dive into the research topics where Jens Tijtgat is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots or
Research output
-
A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab
Awada, G., Jansen, Y., Schwarze, J. K., Tijtgat, J., Hellinckx, L., Gondry, O., Vermeulen, S., Warren, S., Schats, K., van Dam, P-J., Kockx, M., Keyaerts, M., Everaert, H., Seremet, T., Rogiers, A. & Neyns, B., 2 Jan 2021, In : Cancers. 13, 2, p. 1-18 18 p., 168.Research output: Contribution to journal › Article
-
Sexual violence in medical students and specialty registrars in Flanders, Belgium: a population survey
Geldolf, M., Tijtgat, J., Dewulf, L., Haezeleer, M., Degryse, N., Pouliart, N. & Keygnaert, I., 24 Feb 2021, In : BMC Medical Education. 21, 1, 9 p., 130.Research output: Contribution to journal › Article
-
65MO A phase I clinical trial on intratumoural (IT) administration of ipilimumab (IPI) plus nivolumab (NIVO) followed by intracavitary (IC) administration of nivolumab in patients with recurrent glioblastoma
Schwarze, J. K., Bertels, C., Awada, G., Tijtgat, J., Tuyaerts, S., Cras, L., Vaeyens, F., Vanbinst, A-M., Everaert, H., Michotte, A., Caljon, B., Olsen, C., Janssen, T., Van Dooren, S., Forsyth, R., Duerinck, J. & Neyns, B., Dec 2020, In : Annals of Oncology. 31, S7, p. S1443-S1443Research output: Contribution to journal › Meeting abstract (Journal)
-
Intratumoral Combinatorial Administration of CD1c (BDCA-1)+ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial
Schwarze, J. K., Awada, G., Cras, L., Tijtgat, J., Forsyth, R., Dufait, I., Tuyaerts, S., Van Riet, I. & Neyns, B., Dec 2020, In : Vaccines. 8, 4, p. 1-16 16 p., 670.Research output: Contribution to journal › Article
Thesis
-
IMMUNOGENIC CELL DEATH IN ONCOLYTIC VIROTHERAPY: T-VEC in the treatment of cutaneous melanoma
Author: Tijtgat, J., 2019Student thesis: Master's Thesis